MAIA Biotechnology, Inc.MAIANYSE
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank33
3Y CAGR-82.5%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-82.5%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineElevated
PeriodValueYoY Change
20250.02-99.8%
202412.09-62.8%
202332.49+749.0%
20223.83-25.9%
20215.17+136.3%
2020-14.22+94.8%
2019-274.41-